Lasa Supergenerics Limited has filed a disclosure of related party transactions for the quarter and half-year ended September 30, 2026, pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The disclosure contains details of 10 related party transactions with a total value of ₹3.33 crore during the reporting period, all approved by the audit committee with a total approved value of ₹6.40 crore. All transactions had zero opening and closing balances.
Transaction Details:
1. Mr. Omkar Herlekar (Promoter-Managing Director, PAN: AADCL0382Q/ACCPH0802P)
- Type: Directors Remuneration
- Approved value: ₹100 crore
- Transaction value: ₹0.60 crore
2. Mrs Mitti Jain (Company Secretary, PAN: AADCL0382Q/AHHPJ3806B)
- Type: Remuneration
- Approved value: ₹100 crore
- Transaction value: ₹0 crore
3. Ms. Varsha Joshi (CFO, PAN: AADCL0382Q/AIKPJ1632K)
- Type: Remuneration
- Approved value: ₹8 crore
- Transaction value: ₹0.60 crore
4. Dr Omkar Herlekar Foundation (Common Director, PAN: AADCL0382Q/AAHCD7104N)
- Type: Donation Given
- Approved value: ₹200 crore
- Transaction value: ₹0 crore
5. Mr. Yogesh Hari Ughada (Independent Director, PAN: AADCL0382Q/AOAPU2065F)
- Type: Sitting fees for Independent Director
- Approved value: ₹8 crore
- Transaction value: ₹0.15 crore
6. Mr. Pravin Gadalya Lachake (Independent Director, PAN: AADCL0382Q/BBMPL2311R)
- Type: Sitting fees for Independent Director
- Approved value: ₹8 crore
- Transaction value: ₹0.15 crore
7. Mr. Ketan Bhau Songal (Independent Director, PAN: AADCL0382Q/OVGPS4662P)
- Type: Sitting fees for Independent Director
- Approved value: ₹8 crore
- Transaction value: ₹0.15 crore
8. Ms. Rekha Hemant Wakh (Independent Director, PAN: AADCL0382Q/AJGPW9735P)
- Type: Sitting fees for Independent Director
- Approved value: ₹8 crore
- Transaction value: ₹0.15 crore
9. Mr. Ganesh Potdar (Whole Time Director, PAN: AADCL0382Q/APTPP4321H)
- Type: Directors Remuneration
- Approved value: ₹100 crore
- Transaction value: ₹1.43 crore
10. Mr. Janardan Kamlu Savala (Independent Director, PAN: AADCL0382Q/KLAPS8036P)
- Type: Directors Remuneration
- Approved value: ₹100 crore
- Transaction value: ₹0.10 crore
Total Summary:
- Total approved value by audit committee: ₹640 crore
- Total transaction value during reporting period: ₹3.33 crore
- All transactions had zero opening and closing balances
- No transactions involved loans, inter-corporate deposits, advances, or investments
The document was digitally signed by Omkar Pravin Herlekar (DIN: 01587154), Chairman and Managing Director, on November 14, 2026, at 18:10:36 IST.
#LasaSupergenerics #SEBILODR #Regulation23(9) #RelatedPartyTransactions #CorporateGovernance #Neutral